Market Cap (In USD)
122.61 Million
Revenue (In USD)
4.11 Million
Net Income (In USD)
-67.33 Million
Avg. Volume
2295.00
- Currency
- USD
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 5.55-15.53
- PE
- -
- EPS
- -
- Beta Value
- 0.749
- ISIN
- AU0000088841
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Mr. Wayne Geoffrey Paterson
- Employee Count
- -
- Website
- https://www.anteristech.com
- Ipo Date
- 2013-12-09
- Details
- Anteris Technologies Ltd operates as a structural heart company. It manufactures and sells ADAPT, a regenerative tissue product. The company also engages in the developing of DurAVRTM, a 3D single piece aortic valve for the treatment of aortic stenosis. In addition, it researches and develops regenerative medicines. The company was formerly known as Admedus Limited and changed its name to Anteris Technologies Ltd in May 2020. Anteris Technologies Ltd was incorporated in 1999 and is based in Toowong, Australia.
More Stocks
-
MTI
-
BXRDF
-
HUMXHuman Xtensions Ltd.
HUMX
-
SAGASaga Pure ASA
SAGA
-
CPTRCaptor Capital Corp.
CPTR
-
KLGDFKalo Gold Corp.
KLGDF
-
DHAMPUREDhampure Speciality Sugars Limited
DHAMPURE
-
TGOPY3i Group plc
TGOPY